Search Results for: Aphria
Tilray Brands, Inc. Reports Record Fiscal Year 2022 Results
FY2022 Net Revenue Grew 22% to $628 Million Compared to the Prior Year; On a Constant Currency…
Tilray Brands Reports Third Quarter Fiscal Year 2022 Financial Results
Profitable Quarter Includes Net Income of $52.5 Million and Adjusted EBITDA of $10.1 Million; 12th Consecutive…
Tilray Brands Consolidates its Global Medical Offering into Tilray Medical
Tilray Brands, Inc. (“Tilray” or the “Company”) (Nasdaq: TLRY; TSX: TLRY), a leading global cannabis-lifestyle and…
Tilray, Inc. Reports Profitable Second Quarter Fiscal Year 2022 Financial Results
New Parent Company Name, TILRAY BRANDS, Reflects Growing Portfolio of Leading, Global CPG Brands Net…
Hollister Biosciences Announces Q3 2021 Financial Results – Revenue of $14.5M and Adjusted Ebitda of USD $1.2M
Revenue of $14.5 million increased 53% from prior year period Gross profit income of $3.5…
Hollister Biosciences Inc. Announces Results of Its 2021 Annual General and Special Shareholder Meeting
Hollister Biosciences Inc. (CSE: HOLL) (OTC: HSTRF) (FRANKFURT: HOB) (the “Company” or “Hollister Biosciences“) today…
Tilray Hosts 2021 Annual Meeting of Shareholders
Chairman and CEO Irwin D. Simon Affirms Global Growth Strategy, Driven by Strong Positioning across…
Tilray Strengthens Leadership Position in Canada
Tilray, Inc. (“Tilray” or the “Company”) (NASDAQ: TLRY; TSX: TLRY) announces the expansion of its leadership team…
Hollister Biosciences Inc. Announces strategic initiatives including a planned rebrand, executive and board updates
Jake Cohen appointed as CEO Eula Adams, MBA, CPA appointed as Interim CFO and a nominated…
Tilray, Inc. Reports First Quarter Fiscal Year 2022 Financial Results
Net Revenue and Gross Profit Increased 43% and 46%, Respectively, for Largest Global Cannabis Cultivator…
Recent Comments